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Background: Stress echocardiography (SE) is used in patients undergoing liver transplant surgery (LTS) for cardiac event risk assessment. 
However, the utility of this test for underlying coronary disease remains less well established and controversial in prior publications. Hence, we 
sought to evaluate this among patients who underwent SE and subsequently LTS.
Methods: Patients who had LTS between 2001- 2005 were studied. The three outcomes analyzed were non-fatal myocardial infarction (MI), death 
or either outcome over a follow up period of 1.3 ± 0.8 years. Salient variables of clinical demographics, cardiac medications, EKG findings, and 
postoperative complications were included in the analysis.
Results: Of 356 patients (mean age 51±9 years, 65% male), 89 (25%) were diabetic, 74 (21%) hypertensive and 150 (42%) had history of 
smoking. Of these, 27 (7.6%) experienced at least one MI, 44 (12.4%) died and 54 (15.2 %) had either outcome within the long term follow up 
period. Multivariate predictors of long term adverse cardiac outcomes and sensitivity, specificity, positive predictive value and negative predictive 
value of stress echo results are shown in tables 1 and 2, respectively.
Conclusion: The utility of SE among patients undergoing LTS is limited with no association between abnormal results and adverse long term 
cardiac outcomes. However, as previously reported, normal SE response in these patients is associated with a high negative predictive value and 
able to identify the lower risk patients. 
Table 1
Multivariate Predictors Odds Ratio 95 % Confidence Interval P-values
Outcome: Myocardial Infarction
History of Coronary Disease 3.8 1.2-12.6 0.03
History of Stroke 7.7 1.8-33.0 0.006
Outcome: Death
History of Coronary Disease 4.9 1.3-18.4 0.02
ACE/ARB Use 4.2 1.3-13.8 0.02
Postoperative Sepsis 16.1 6.5-40.1 <0.0001
Perioperative Beta Blockers 0.07 0.01-0.32 0.0008
Outcome: Combined MI/Death
History of Coronary Disease 5.7 1.8-17.6 0.003
Diuretic Use 0.49 0.26-0.95 0.03
Postoperative Sepsis 11.7 5.0-27.2 <0.0001
Perioperative Beta Blockers 0.26 0.10-0.67 0.005
Table 2
Outcomes
MI
Death
Combined Death/MI
